Rafferty Asset Management, LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1389426
New York, NY
Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,540,417
-$661,513 QoQ
Shares Held
162,703
-16.7% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. SRPT ranks #45 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,540,417 | 162,703 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,201,930 | 195,257 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,374,851 | 175,135 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,560,896 | 149,760 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,324,881 | 99,105 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,282,005 | 109,236 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,240,065 | 138,042 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,160,272 | 146,584 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,546,250 | 73,739 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,947,043 | 103,153 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,992,099 | 74,180 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,444,258 | 65,004 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,704,878 | 48,646 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,152,753 | 70,634 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,724,258 | 60,831 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,522,111 | 60,327 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,772,521 | 73,893 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,953,295 | 66,111 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,102,320 | 44,359 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,358,009 | 30,332 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,871,193 | 38,524 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $950,311 | 5,574 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,131,867 | 15,181 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $973,584 | 6,072 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $351,173 | 3,590 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||